|

SHR2554 tablets Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Jiangsu HengRui Medicine Co., Ltd.2

Indications

  • Cancer2
  • Advanced Gastric Cancer1
  • Gastroesophageal Junction Adenocarcinoma1
  • Metastatic Gastric Cancer1
  • Prostate Cancer1

Other2 trials

A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
Phase 1/2
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.